Is Baxter International Inc (BAX) undervalued? · rev $2.75B
Baxter International Inc (BAX) is a medical instruments & supplies company listed on NYSE.
This page asks whether Baxter International Inc (BAX) looks cheap on cached numbers — not a DCF toy and not a buy alert.
Latest reported BAX revenue for 2024-12-31 was $2.75B. Net income was -$510.0M. Revenue was up 2.0% from 2024-09-30 to 2024-12-31. BAX currently screens at market cap $10.01B.
BAX currently screens at market cap $10.01B. Cheap versus history or peers still needs a filing reason; a low multiple can be a value trap.
A new BAX 10-Q can flip this screen overnight. The SEC page is the source.
Not investment advice. Compare BAX to the stock page model before you treat a low multiple as a gift.
Not investment advice.